These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3991534)

  • 1. Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patients.
    Fournier A; Sebert JL; Fohrer P; Moriniere P; Lambrey G; Herve MA; Leflon P; Gueris J; Garabedian M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():415-20. PubMed ID: 3991534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.
    Fournier A; Fohrer P; Leflon P; Moriniere P; Tolani M; Lambrey G; Demontis R; Sebert JL; Van Devyver F; Debroe M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():371-6. PubMed ID: 3991525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites.
    Ittel TH; Hofstädter F; Gladziwa U; Sieberth HG
    Nephrol Dial Transplant; 1989; 4(11):957-65. PubMed ID: 2516887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histological classification of uremic bone disease and clinical significance of bone biopsy].
    Zhu JM; Alfrey AC; Huffer WE
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):444-7. PubMed ID: 8275820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study.
    Woitge HW; Knothe A; Witte K; Schmidt-Gayk H; Ziegler R; Lemmer B; Seibel MJ
    J Bone Miner Res; 2000 Dec; 15(12):2443-50. PubMed ID: 11127208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis.
    Lange U; Jung O; Teichmann J; Neeck G
    Osteoporos Int; 2001 Dec; 12(12):1031-5. PubMed ID: 11846329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
    Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Pasquali M; Perruzza I; Manni M; Sardella D
    Miner Electrolyte Metab; 1991; 17(3):153-9. PubMed ID: 1779936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of bone metabolism in hemodialysis patients. I. Correlation with bone histology and serum levels of PTH, vitamin D metabolites, and vitamin A].
    Ohara K
    Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):417-36. PubMed ID: 3230693
    [No Abstract]   [Full Text] [Related]  

  • 19. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
    Joffe P; Heaf JG; Jensen LT
    Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.